Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Depreciation and Depletion (2016 - 2017)

Historic Depreciation and Depletion for Tenax Therapeutics (TENX) over the last 7 years, with Q4 2017 value amounting to $2621.0.

  • Tenax Therapeutics' Depreciation and Depletion fell 3367.91% to $2621.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $12621.0, marking a year-over-year decrease of 3340.54%. This contributed to the annual value of $7570.0 for FY2023, which is 4719.04% up from last year.
  • As of Q4 2017, Tenax Therapeutics' Depreciation and Depletion stood at $2621.0, which was down 3367.91% from $3000.0 recorded in Q3 2017.
  • Over the past 5 years, Tenax Therapeutics' Depreciation and Depletion peaked at $23000.0 during Q1 2013, and registered a low of $2621.0 during Q4 2017.
  • Moreover, its 5-year median value for Depreciation and Depletion was $16836.0 (2015), whereas its average is $13561.5.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first changed by 0.0% in 2013, then crashed by 4090.91% in 2015.
  • Quarter analysis of 5 years shows Tenax Therapeutics' Depreciation and Depletion stood at $23000.0 in 2013, then dropped by 8.7% to $21000.0 in 2014, then plummeted by 38.1% to $13000.0 in 2015, then crashed by 69.6% to $3952.0 in 2016, then plummeted by 33.68% to $2621.0 in 2017.
  • Its Depreciation and Depletion was $2621.0 in Q4 2017, compared to $3000.0 in Q3 2017 and $3000.0 in Q2 2017.